McGill University Department of

McGILL OPHTHALMOLOGY CLINICAL DAY 2016

Cataracts

Centre Mont-Royal 2200 Mansfield, International Room Montreal, Quebec

Friday, June 3, 2016

Featuring: Warren Hill, MD, FACS Bonnie Henderson, MD Kashif Baig, MD, CM, MBA Paul Harasymowycz, MD,MSC Sébastien Gagné, MD and faculty of the McGill Department of Ophthalmology

ORGANIZED BY: Hady Saheb, MD, MPH, Chair, McGill Ophthalmology Day Planning Committee Leonard A. Levin, MD, PhD, Chair, McGill Department of Ophthalmology Mahshad Darvish MDCM, MBA, Marino Discepola MD, John Galic MD

Agenda

7:00 – 8:00 a.m. Registration and Breakfast

8:00 – 8:05 a.m. Introduction by McGill University Department of Ophthalmology Chairman Leonard A. Levin MD, PhD

8:05 – 8:10 a.m. Introduction by McGill Day 2016 Chair Hady Saheb MD, MPH

CATARACTS: BACK TO THE FUTURE

8:10 – 8:30 a.m. History of – From Cryo to Femto in 40 Years Susan Lindley, MD

8:30 – 8:35 a.m. Discussion (5 min)

Femtosecond Laser-Assisted Cataract Surgery (FLACS):

8:35 – 8:45 a.m. What is the Evidence? Paul Harasymowycz MD, MSC

8:45 – 9:05 a.m. Panel on Surgical Pearls and Pitfalls Paul Harasymowycz MD, MSC Sébastien Gagné, MD Conrad Kavalec, MD

9:05 – 9:15 a.m. The Role of FLACS in the Public System Conrad Kavalec, MD

9:15 – 9:20 a.m. Discussion (5 min)

9:20 – 9:35 a.m. Splash: What’s New in Cataract Surgery?

Intraoperative Aberrometry Mikel Mikhail, MD

iTrace Lauren French, MD

Dropless Cataract Surgery: Intravitreal Injections Darren Albert, MD

9:35 – 9:40 a.m. Discussion

9:40 – 10:05 a.m. THE DARIO LORENZETTI LECTURE: IOL Power Calculation Based in Pattern Recognition, Independent of Vergence Formulas and the Effective Position Warren E. Hill, MD, FACS

10:05 – 10:10 a.m. Discussion

10:10 – 10:20 a.m. Resident Involvement in Cataract Surgery Jean Deschênes, MD

10:20 – 10:30 a.m. Discussion

10:30 – 10:50 a.m. Break

ATIOLS

10:50 - 11:10 a.m. Presbyopic Correction Marino Discepola, MD

All about TORICS

11:10 – 11:15 a.m. Barrett + Olsen Susan Wakil, MD

11:15 – 11:30 a.m. Preoperative Measurements and Corneal Marking Techniques, and Do We Need Them Anymore? Mahshad Darvish-Zargar, MD, MBA

11:30 – 11:45 a.m. Postop IOL Rotation: How to Prevent, Diagnose, and Treat Darren Albert, MD

11:45 – 12:05 p.m. Discussion

12:05 – 12:15 p.m. Practice Management: ATIOLs in the Public System Marino Discepola, MD

12:15 – 12:25 p.m. Post-Refractive IOL Calculations Johanna Choremis, MD

12:25 – 12:45 p.m. THE SEAN MURPHY LECTURE: Negative Dysphotopsias – the Unsolved Mystery Bonnie An Henderson, MD

12:45 – 1:00 p.m. Discussion

1:00 – 1:45 p.m. LUNCH

CATARACTS AND COMORBIDITIES

1:45 – 1:55 p.m. Top 5 Things to Know if Operating on a Retina Patient John Galic, MD

1:55 – 2:05 p.m. Top 5 Things to Know if Operating on a Glaucoma Patient Hady Saheb, MD, MPH

2:05 – 2:15 p.m. Top 5 Things to Know if Operating on a Cornea Patient Devinder Cheema, MD

2:15 – 2:25 p.m. Top 5 Things to Know if Operating on a Uveitis Patient Karin Oliver, MD

2:25 – 2:35 p.m. Top 5 Things to Know if Operating on a Strabismus Patient Michael Flanders, MD

2:35 – 2:45 p.m. Discussion

2:45 – 3:05 p.m. Understanding Corneal Aberrations Warren E. Hill, MD, FACS

3:05 – 3:15 p.m. Discussion

3:15 – 3:35 p.m. Break

UH OH: KEEPING YOUR COOL IN DIFFICULT CASES

3:35 – 3:50 p.m. Houston, We Have a Problem: Management of Complicated Cases Bonnie An Henderson, MD

3:50 – 4:10 p.m. Discussion

4:10 – 4:20 p.m. Posterior Polar Cataracts Sébastien Gagné, MD

4:20 – 4:30 p.m. Vitrectomy for the Anterior Segment Surgeon Michael Kapusta, MD

4:30 – 4:50 p.m. When the Capsule is Gone: IOL Options and How to Choose Kashif Baig, MD, CM, MBA

4:50 – 5:05 p.m. Discussion

5:05 – 5:25 p.m. Resident Complication Panel: What Would You Do If You Were Supervising Surgeon in This Case? Rayan Al-Shareef MD, Darren Albert MD, Hady Saheb MD MPH, Bonnie An Henderson MD, Kashif Baig, MD CM MBA

5:25 – 5:30 p.m. Closing Remarks Hady Saheb, MD, MPH

LEARNING OBJECTIVES FOR THE McGILL OPHTHALMOLOGY CLINICAL DAY June 3, 2016 Centre Mont-Royal, Montréal, Québec

At the end of the program, participants will be able to:

. Compare different methods of preparing for the implementation of TORIC lenses

. Assess possible reasons for an unhappy patient following cataract surgery

. Contrast intricacies of cataract surgery in patients with ocular comorbidities

. Build on current approaches of managing intraoperative complications

. Discuss the impact these recent developments could have on their practice.

How did we do? Please evaluate your experience at today’s McGill Ophthalmology Clinical Day by completing the survey at https://www.surveymonkey.com/r/GCHTYV7 Your responses will help us plan for next year.

Applying for CME Credit?

This meeting is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada. This meeting was approved by the Canadian Ophthalmological Society. Physicians may claim a maximum of 8 hours.

Physicians should only claim credit commensurate with the extent of their participation in the learning activity.

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.”

To receive a certificate of attendance in order to claim credits, please complete the survey at https://www.surveymonkey.com/r/GCHTYV7

We will be pleased to send you a certificate by email upon completion of the survey.

Bonnie An Henderson is an internationally-recognized expert in cataract and refractive surgery, specializing in complicated anterior segment surgery. She is currently a partner at Ophthalmic Consultants of and a Clinical Professor at School of . Dr. Henderson is the Associate Editor for the Journal of Refractive Surgery and Associate Editor for Eyeworld for the American Society of Cataract and Refractive Surgery. She serves on the editorial advisory board of Eyenet Magazine of the American Academy of Ophthalmology, and serves on the editorial boards of Ocular Surgery News, Cataract and Refractive Surgery Today, and Advanced Ocular Care. She serves on a number of committees for the American Academy of Ophthalmology and the American Society of Cataract and Refractive Society. She will serve as the President of American Society of Cataract and Refractive Surgery in 2017.

Dr. Henderson has authored over 125 articles, papers, book chapters, and abstracts and has delivered over 275 invited lectures worldwide. She has published 4 textbooks in cataract and refractive surgery with her 5th book due out in 2015. Her textbook, Essentials of Cataract Surgery, is one of the most commonly used textbooks to teach cataract surgery in the United States. Dr. Henderson’s principal research involves cataract surgery outcomes and innovative methods of teaching, including the development of a digital-based method for teaching cataract surgery, supported by a Department of Defense TATRIC grant. She has invented and commercialized a number of medical instruments including the modified capsule tension ring, astigmatism correcting markers, and a capsule polisher, for which she donates her interests to charity.

Dr. Henderson has been awarded an Achievement Award, the Secretariat Award, and the Senior Achievement Award by the American Academy of Ophthalmology, “Best of” awards from the American Society of Cataract and Refractive Surgery for her research and films, and the “Teacher of the Year” award from Harvard Medical School. She has been awarded the Visionary Award by the American- European Congress of Ophthalmic Surgery and received the Suzanne Veronneau-Troutman Award from Women in Ophthalmology. She has been chosen by her peers nearly every year for the past consecutive 12 years as “Top Doctor” by Boston Magazine, as “Top 100 Doctors in the United States” by the US New Report, “Top Doctor” by Castle Connolly, and a “Top Surgeon” by Becker’s ASC Report.

Dr. Henderson completed her ophthalmology at Harvard Medical School, Massachusetts Eye and Ear Infirmary. She graduated from Dartmouth College and from Dartmouth Medical School with high honors. She serves on the Board of Overseers at the Geisel School of Medicine at Dartmouth, the Executive Committee of American Society of Cataract and Refractive Surgery, the Executive Board of the Massachusetts Society of Eye Physicians and Surgeons, and has served on the Physician Board of Directors at the Massachusetts Eye and Ear Infirmary. Married with three children, her interests include culinary arts and competing in triathlons. Dr. Warren Hill has been in private practice in Mesa, Arizona for the past 30 years. He completed his ophthalmology training at the University of Rochester in New York and has since devoted his career to challenging anterior segment surgery and the mathematics of power calculations. He is best known for his work helping physicians to obtain accurate IOL power calculations. His web site doctor-hill.com and the ASCRS post-refractive calculator, developed with Doug Koch and Li Wang, are two of the most popular IOL power calculation resources in ophthalmology, with a combined total of over 200,000 visits per year.

Dr. Hill has published extensively, served as visiting professor for grand rounds at many institutions, has delivered 18 named lectureships and has made 650 presentations at both national and international meetings in 36 countries. In 2007 Dr. Hill was appointed the Cataract and Anterior Segment Subspecialty Editor for the American Academy of Ophthalmology's Ophthalmic News and Education (O.N.E.) Network, a position he held until 2010. He has performed live surgery at ophthalmology meetings in North America, South America and Europe and is a member of the prestigious International Intraocular Implant Club. In 2014, Dr. Hill gave the American Society of Cataract and Refractive Surgery Innovator's Lecture and in 2015 he gave the American Academy of Ophthalmology’s Charles Kelman Lecture.

Aside from the practice of ophthalmology, Dr. Hill’s other passion is flying military airplanes in air shows as a member of a close formation demonstration team for which is licensed as a multi-engine commercial pilot. Each year, his team regularly performs at a wide variety air shows, including the EAA (Oshkosh) AirVenture, the largest air show in North America.

Kashif Baig

Dr. Baig is a Cornea, Anterior Segment, and Refractive Surgeon providing tertiary and quaternary level care at the University of Ottawa Eye Institute. He is the President of the Canadian Cornea, External Disease, and Refractive Surgery Society. He is also an Assistant Professor at the University of Ottawa, Cornea Consultant at the Children's Hospital of Eastern Ontario, Clinical Investigator in Regenerative Medicine at the Ottawa Hospital Research Institute, and Director of Clinical and Research Fellowships in Cornea, Anterior Segment, and Refractive Surgery.

He has delivered over 100 lectures; has done over 120 research paper and poster presentations; has instructed courses at ESCRS, ASCRS, and COS; and has trained 12 clinical and research fellows in the last 7 years. He completed his medical and residency training at McGill University, Master of Business Administration Degree (specializing in Health Services Management) at McMaster University, and Fellowship training in the United States. He has a strong interest in the development and implementation of surgical innovations in corneal and anterior segment surgery.

Sébastien Gagné

Dr. Gagné’s primary interests are in surgical glaucoma, phacorefractive surgery and clinical research. He studied medicine at the Université de Sherbrooke from 1997 to 2001 and completed his specialty training in ophthalmology there in 2006. In 2007, in the aim of furthering his knowledge and learning new surgical techniques, he completed a one-year subspecialty training program at the University of Toronto under the supervision of Drs. Ike K. Ahmed and Thomas B. Klein. A glaucoma expert, he has developed expertise in the treatment of complicated cataract cases and in the reconstruction of the anterior segment.

A member of the Royal College of Physicians and Surgeons of Canada and a research clinician, Dr. Gagné is also professor of clinical teaching at the Faculty of Medicine of the Université de Montréal and participates in the training of future ophthalmologists at the Centre hospitalier de l’Université de Montréal (CHUM), Hôpital Notre- Dame since 2007. Dr. Gagné is a founding member and medical director of the Institut de l’oeil des Laurentides. He is a fan of hockey and Star Wars, and is the proud father of two sons and a daughter.

Paul Harasymowycz

Throughout his career, Dr Harasymowycz has devoted himself to teaching, researching and medical entrepreneurship. After finishing his studies in medicine, he pursued a residency at the Université de Montréal as chief resident. After completing his fellowship at the Will’s Eye Hospital in Philadelphia in 2001, he started working as a clinician, surgeon and researcher at Maisonneuve-Rosemont Hospital and at the Centre de recherche Guy- Bernier. In parallel, he has also been teaching at the ophthalmology department of the Université de Montréal where today he is chief of glaucoma. His interest in and devotion to the treatment of glaucoma led him to found the Bellevue Ophthalmology Clinics, the Montreal Glaucoma Institute and the Quebec Glaucoma Foundation.

Dr Harasymowycz has received many research grants and his research focuses primarily on the detection of glaucoma and new surgical treatment options and techniques for glaucoma surgery and cataract surgery. He has a passion for teaching medical students, residents and fellows in glaucoma. He is solicited nationally and internationally to present and teach surgical techniques at professional congresses, specialist meetings and universities. He is a member of the glaucoma committee of the American Society of Cataract and Refractive Surgery (ASCRS) and the Board of the Association des Médecins Ophtalmologistes du Québec (AMOQ). He has published over fifty articles in scientific peer-reviewed journals and has authored chapters on glaucoma in several published books.

Biography of Dr. Sean Murphy (1924 - )

A 1943 graduate of Harvard, Dr. Murphy received his department. He also helped develop a strong McGill medical degree from McGill in 1947. From 1952 to Ocular Pathology unit with Drs. Mourad Khalil, 1955 he served in the Royal Canadian Air Force, Esmond Gordon and Seymour Brownstein, and where he was in charge of ophthalmological encouraged the development of the Low Vision services. Then in 1955 he joined the McGill Clinic. He participated in the meetings of the Cogan Department of Ophthalmology and the staff of the Ophthalmic History Society and the American Osler RVH. For eighteen years thereafter he saw Society. consultations from the MNI and taught neuro- ophthalmology, at the same time gradually Realizing that ophthalmology was under-valued in furthering his practice of retinal surgery. hospitals and universities across Canada, Dr. Murphy accepted several administrative positions outside of In 1970 Dr. Murphy was appointed Ophthalmologist- McGill and its teaching hospitals. He became in-Chief at the RVH, and Professor and Chairman of President of the Canadian Ophthalmological Society, the McGill Department of Ophthalmology in 1975. President of the Association des médecins The Dean, Dr. Samuel O. Friedman, gave him a ophtalmologistes du Québec, and for two years was mandate to unify the department and create a Chief Examiner of the Royal College. He was harmonious relationship between the four hospital awarded the Order of Canada in 1976, the medal of departments. This was no easy matter as the the Canadian Ophthalmological Society in 1987, and Chairman had virtually no authority over the in 2007 received the society’s Lifetime Achievement hospital departments. Award. In 1989 the Department of Ophthalmology established an annual lecture in his honour. His first initiative was to form a McGill departmental Executive Committee. The four hospital chiefs were He established the annual Clinical and Scientific Day invited to be members. They were Dr. Dario in 1978 with the help of Dr. Bruce Jackson. It Lorenzetti (MGH), Dr. John Little (MCH), Dr. Joel continues to the present day, and provides a forum Rosen (JGH), and Dr. Murphy (RVH). The Executive for the residents to present the results of their Committee met regularly, once a month, and among research – the research being done with supervision the many subjects discussed were: residents, of a member of the staff. Dr. Murphy believed medical students, teaching, staff GFTs, recruitment, strongly in community activities and for ten years subspecialization, research, fund raising, space, was President of the Montreal Museum of Fine Arts, amalgamation, and the development of centers of which involved being an active fundraiser for the excellence. museum, a position which frequently helped in the search for funds for academic ophthalmology. McGill The Executive Committee proved to be successful in and the hospitals did not provide sufficient funds for cementing better interhospital relations. Its creation research as well as the resident program with the was an important step in assuring the future result that funding became a priority. Dr. Murphy development of the department. Dr. Murphy retired as Ophthalmologist-in-Chief at the RVH and promoted the training and recruitment of Chairman of the McGill Department of subspecialists and geographic full-time staff. He felt Ophthalmology in 1986. it was a priority to send graduating residents away for further specialized training and, wherever In 1991 Dr. Murphy was appointed Interim Chairman possible, to offer them GFT positions on their return. of the McGill Department until 1993. He is now a Supporting departmental research, he emphasized retired member of the Department of the importance of having basic scientists in the Ophthalmology and resides in Montreal, Quebec.

Excerpt from History of McGill Department of Ophthalmology’, Sean B. Murphy, 1990. Biography of Dr. Dario Lorenzetti (1936 - 1994)

Dr. Lorenzetti graduated in medicine from McGill in Drs. Bruce Jackson and Joel Rosen. The group was 1960. He then completed the Ophthalmology trying to obtain greater subspecialty amalgamation residency program at the MGH, followed by a between the hospitals, and met for external disease fellowship in external disease with Dr. Herbert clinics regularly in the different hospitals, where Kaufman at the University of , Gainsville. In patients were examined and discussed. 1967, Dr. Lorenzetti returned to the MGH, and was appointed a GFT ophthalmologist. As Chairman of the Postgraduate Committee, he organizing the residents’ rotations and their As a researcher, teacher, and physician, Dr. Thursday morning lectures. The teaching offered in Lorenzetti’s contributions to the MGH and McGill the lectures was of high quality and given roughly in Ophthalmology were important. For example, in the parallel with the American Academy of 1960s little ophthalmological research was being Ophthalmology schedule of subjects. These sessions conducted, either at McGill or at its teaching were instituted in the early 1970s and attended by hospitals. However, one exception to this situation all the residents. Their attendance was mandatory was the work being pursued by Dr. Lorenzetti. After and they were excused from all other duties to arriving at the MGH, he continued his studies in attend. At the conclusion of a series of lectures on a external disease, worked with several Fellows, and given subject area, and after discussion with the supervised corneal research. His research work, teachers involved, a distinguished visiting professor supported by grants, was important, as it signaled in that field was invited to spend time with the the later advent of clinical scientists and furthered residents and give a lecture to the whole the research projects and initiatives previously department. Most frequently these speakers came begun by Dr. Peter Davis at the RVH. from the United States, Canada, and occasionally other countries. Organizing this far-flung training He was a valued member of the departmental program in four hospitals was complex. However, Dr. executive committee, and could be counted on to Lorenzetti always had everything in good order and come up with better ways of doing things. In his submitted on time. Besides being a good organizer administrative functions, Dr. Lorenzetti was an and administrator of medical matters, Dr. Lorenzetti excellent and reliable administrator; one could was also renowned for organizing and participating always count on him. If he said he would do it, it was in festive occasions - especially senior resident done. Indeed his administrative and organizing skills dinners and more informal events. were reflected in his heavy involvement with the MGH project to secure new facilities for the Dr. Lorenzetti was friendly, well liked and his warm hospital’s ophthalmology department and clinic on hearted support of residents and staff was noticed the 6th floor of Livingston Hall. and appreciated by all. He looked after his staff’s interests admirably, often seeking improved funding Beyond his research and teaching duties, as well as and always supporting them. He presented his his official administrative functions, Dr. Lorenzetti points of view to others with clarity and conviction. held a number of additional university and non- Always logical, and a skilled debater, he fought hard university positions. In 1980 he was appointed Chief for what he believed. Understandably, both the Examiner for the Royal College of Physicians and hospital and university community were greatly Surgeons. In addition, an interest in medical saddened by his premature death in 1994 as were education led to his chairing the Canadian his friends and numerous patients. In his honour, the Ophthalmological Society’s Continuing Medical Canadian Ophthalmological Society launched the Education Committee for several years. Also in the annual Dario Lorenzetti Lecture. Similarly, the McGill late 1980s, Dr. Lorenzetti was a member of the Department of Ophthalmology also established an external disease group, composed of himself and annual lecture in memory of Dr. Lorenzetti.

Excerpt from History of McGill Department of Ophthalmology’, Sean B. Murphy, 1990. DARIO W.C. LORENZETTI LECTURES 1996 –

2016 Warren Hill, M.D., F.A.C.S. East Valley Ophthalmology, Mesa, AZ

2015 Christopher J. Rapuano. M.D. Wills Eye Institute, Philadelphia, PA

2013 John G. Flanagan, Ph.D. Vision Science, University of California, Berkeley, CA

2012 Rando Allikmets, Ph.D. Columbia University, New York, NY

2011 Austin Roorda, M.D. University of California, Berkeley, CA

2009 Debra A. Goldstein, M.D. McGill University

2008 Miguel N. Burnier Jr., M.D., Ph.D. McGill University

2007 Peter J. Savino, M.D. Wills Eye Hospital, Philadelphia, PA

2006 James J. Augsburger, M.D. University of Cincinnati College of Medicine, Cincinnati, OH

2005 J. William Harbour, M.D. Bascom Palmer Eye Institute, University of Miami Health System, Miami, FL

2004 Arthur B. Leith, M.D. McGill University

2003 Stephen M. Drance, M.D. University of British Columbia, Vancouver, BC

2002 Alan F. Cruess, M.D. Dalhousie University, Halifax, NS

2001 Donald S. Minckler, M.D. University of California, Irvine, CA

2000 Richard K. Parrish, M.D. Bascom Palmer Eye Institute, University of Miami Health System, Miami, FL

1999 Kenneth R. Kenyon, M.D. New England Eye Centre, Boston, MA

1998 Nabil E. Saheb, M.D. McGill University

1997 Ramon L. Font, M.D. Baylor College of Medicine, Houston, TX

1996 David J. Apple, M.D Medical University of South Carolina, Charleston, SC SEAN B. MURPHY LECTURES 1989 -

2016 Bonnie Henderson, MD, Cornea 2000 Jean Deschênes, MD, Uveitis, Cornea/External Tufts University School of Medicine Disease Department of Ophthalmology, McGill 2015 Todd Margolis, MD, PhD, Uveitis University Washington University School of Medicine, USA 1999 Lanning Kline, MD, Neuro-Ophthalmology 2014 Richard K. Parrish II, MD, Glaucoma Birmingham, Alabama Bascom Palmer Eye Institute, Miami, Florida, USA 1998 Rubens Belfort, MD, Cornea/External Disease Sao Paulo, Brazil 2013 Emily Chew, MD, Retina National Institutes of Health (NIH), Bethesda, 1997 Raymond Leblanc, MD, Glaucoma Maryland, USA Halifax, Nova Scotia

2012 George B. Bartley, MD, Oculoplastics 1996 Frederick Jakobiec, MD, Ophthalmic Mayo Clinic in Florida, Rochester, Minnesota, Oncology/Ophthalmic Pathology USA Massachusetts Eye and Ear Infirmary, Boston, Massachusetts 2011 Harry A. Quigley, MD, Glaucoma Wilmer Ophthalmological Institute, John 1995 Duncan Anderson, MD, Neuro-Ophthalmology Hopkins University School of Medicine, Vancouver, British Columbia Baltimore, MD 1994 Lorenz E. Zimmerman, MD, Ophthalmic 2010 Sohan Hayreh, MD, Neuro-Ophthalmology Pathology University of Iowa, USA Armed Forces Institute of Pathology, Washington, D.C. 2009 Warren Hill, MD, Cataracts East Valley Ophthalmology, Mesa, Arizona 1993 Howard Tanenbaum, MD, Vitreoretinal Albany, New York 2008 Dr. Nabil Saheb, Glaucoma Department of Ophthalmology, McGill 1992 Mark Abelson, MD, Cornea/External University Disease/Optics/Refraction Boston, Massachusetts 2007 Neil Miller, MD, Neuro-Ophthalmology Johns Hopkins Hospital, Baltimore, Maryland 1991 Elliott B. Werner, MD, Glaucoma Philadelphia, Pennsylvania 2006 Bryan Arthurs, MD, Oculoplastics Department of Ophthalmology, McGill 1990 E.R. Simpson, MD, Ocular Oncology University Toronto, Ontario

2005 Stanley Chang, MD, Retina 1989 Brian Yonge, MD Columbia University, New York, N.Y. Mayo Clinic, Rochester, Minnesota

2004 John T. Flynn, MD, Pediatric Ophthalmology/Strabismus Harkness Eye Institute, New York, N.Y.

2003 Alain Rousseau, MD, Retina/Ocular Pathology Laval University, Quebec City

2002 Jerry Shields, MD, Ophthalmic Oncology/Retina Vitreous Will’s Eye Institute, Philadelphia, Pennsylvania

2001 Bruce Jackson, MD, Cornea/External Disease University of Ottawa Eye Institute, Ottawa

The Department of Ophthalmology, McGill University wishes to thank the following companies for their support of the Department, for the 39th Annual McGill Ophthalmology Research Day 2016 and throughout the years.

Gold sponsor:

Silver sponsor:

Bronze sponsor:

see what we see

Allergan markets a portfolio of best-in-class products that provide valuable treatments for the eye care, central nervous system, medical aesthetics, gastroenterology, women’s health, urology, cardiovascular and anti-infective therapeutic categories, providing patients around the globe with increased access to affordable, high-quality .

Allergan is an industry leader in research and development, with one of the broadest development pipelines in the pharmaceutical industry.

FOR MORE INFORMATION, VISIT THE ALLERGAN BOOTH

AND TALK TO A REPRESENTATIVE.

TM/® MARKS ARE OWNED BY ALLERGAN INC. XEN® IS A REGISTERED TRADEMARK OF AQUESYS, INC., AN ALLERGAN AFFILIATE, USED UNDER LICENSE BY ACTAVIS SPECIALTY PHARMACEUTICALS CO. © 2016 ALLERGAN. ALL RIGHTS RESERVED. APC08JS16

ALL17698_01_RetinaSocietyConf_ProgramAd_EN.indd 1 2016-01-29 9:41 AM

ALL17698_01_Retina Society Conference Program Ad EN 3 5 17698_01 Lora 4/0 – cmyk Notepad 7.5"x9.5" 100% DrH, CC 01/28/16 Allergan Kendra .125" within

PMS PMS PMS PMS PMS FOIL N/A 100% By 2050 the world’s population over and cardiovascular conditions, 60 will have doubled to two billion, solutions for eye diseases, or ways making age-related illness an even to keep those with arthritis moving. greater challenge for society. Because life shouldn’t stop at 60 – That’s why we’re seeking to help not by any means. people stay healthier and more To find out how our innovations are active in later life, be it through helping to change lives for the better, more targeted treatments for cancer visit www.bayer.ca Each day, we have 14 billion little reminders to continue advancing eye health.

From the moment we open our eyes and start to view the possibilities of each new day, we look at how we can improve the well-being of the world’s 14 billion eyes. Will this be the day when one of us unlocks a way to eliminate visual impairment in newborns? Or strikes upon a treatment that actually helps the eye heal itself? To us, these are not some distant hopes. They are the daily questions that add new urgency to all we do and everything we see for the future. We’re Bausch + Lomb, a company solely focused on advancing the vision and care of the world’s eyes.

© 2016 Bausch & Lomb Incorporated. BLS05655 TP12894 Novartis Pharmaceuticals Canada Inc. is one of the country’s leading healthcare companies committed to improving the health of Canadians.

We strive to discover and develop medicines that make a real difference.

There can be no delay.

Patients are waiting.

Novartis Pharma Canada inc. est un chef de file national dans le domaine de la santé qui s’engage à améliorer la santé des patients.

Nous aspirons à découvrir et à mettre au point des médicaments qui font une véritable différence.

Il faut accélérer le pas.

Les patients attendent.

www.novartis.ca

16-0238-Novartis-FP-EN-CMYK-ClinicalDay-v2.indd 1 2016-05-13 4:12 PM